IRIS
MANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.405
AS - Asia 2.162
EU - Europa 1.724
SA - Sud America 339
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 79
OC - Oceania 1
Totale 7.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.268
CN - Cina 954
SG - Singapore 486
IE - Irlanda 350
HK - Hong Kong 254
BR - Brasile 249
IT - Italia 240
VN - Vietnam 230
RU - Federazione Russa 207
DE - Germania 198
FI - Finlandia 164
UA - Ucraina 155
SE - Svezia 105
FR - Francia 102
GB - Regno Unito 94
CA - Canada 62
BD - Bangladesh 54
ZA - Sudafrica 45
IN - India 37
AR - Argentina 24
EC - Ecuador 19
BE - Belgio 18
MX - Messico 18
CO - Colombia 17
ES - Italia 17
JP - Giappone 17
PK - Pakistan 17
IQ - Iraq 14
NL - Olanda 14
TR - Turchia 14
CZ - Repubblica Ceca 13
ID - Indonesia 13
PL - Polonia 13
CR - Costa Rica 11
TT - Trinidad e Tobago 10
PH - Filippine 9
SA - Arabia Saudita 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
MA - Marocco 8
MY - Malesia 8
GT - Guatemala 7
JM - Giamaica 6
PE - Perù 6
TN - Tunisia 6
HN - Honduras 5
KZ - Kazakistan 5
UZ - Uzbekistan 5
IL - Israele 4
JO - Giordania 4
LT - Lituania 4
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
EG - Egitto 3
KE - Kenya 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CU - Cuba 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KW - Kuwait 2
MD - Moldavia 2
MQ - Martinica 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
GN - Guinea 1
GR - Grecia 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 7.700
Salva come PNG Salva come JPEG
Città #
San Jose 383
Dublin 347
Chandler 324
Ashburn 270
Singapore 252
Hong Kong 244
Jacksonville 222
Dallas 206
Council Bluffs 202
Beijing 177
Nanjing 169
Boardman 104
Ho Chi Minh City 84
New York 81
Nanchang 77
Los Angeles 75
Princeton 73
Lauterbourg 70
Lawrence 66
Wilmington 65
Changsha 63
Munich 60
Ann Arbor 57
Helsinki 57
Hebei 56
Shenyang 56
Hanoi 54
Santa Clara 49
Jiaxing 41
Medford 40
Johannesburg 39
Pavia 39
Shanghai 39
Milan 38
Buffalo 33
Moscow 30
Redondo Beach 30
Tianjin 26
Montreal 25
São Paulo 23
Piscataway 22
Hangzhou 21
Da Nang 20
Turku 20
Rome 19
Brussels 18
North Bergen 18
Toronto 18
Brooklyn 15
Atlanta 14
Columbus 14
Tokyo 14
Phoenix 13
Seattle 13
Woodbridge 13
Frankfurt am Main 12
Houston 12
The Dalles 12
Denver 11
Rio de Janeiro 11
Warsaw 11
Washington 11
London 10
Nuremberg 10
San Francisco 10
Zhengzhou 9
Baghdad 8
Brno 8
Mexico City 8
Norwalk 8
Orem 8
Stockholm 8
Amsterdam 7
Boston 7
Chennai 7
Fairfield 7
Guatemala City 7
Medellín 7
Quito 7
San José 7
Brasília 6
Chaguanas 6
Guayaquil 6
Haiphong 6
Manchester 6
Naples 6
Porto Alegre 6
Turin 6
Guangzhou 5
Guarulhos 5
Kingston 5
Kunming 5
Las Vegas 5
Mumbai 5
Newark 5
Poplar 5
Ribeirão Preto 5
Santiago 5
Secaucus 5
Tappahannock 5
Totale 4.929
Salva come PNG Salva come JPEG
Nome #
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 157
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 153
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 147
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 146
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome 131
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 130
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium 129
T o B nell’Artrite Reumatoide 127
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 127
Chemochine linfoidi nella sinovite reumatoide 125
Synovial tissue research: a state-of-the-art review 124
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 124
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study 123
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? 123
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 122
B cell autoimmunity and bone damage in rheumatoid arthritis 122
Current concepts and new developments in the treatment of psoriatic arthritis 122
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 120
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 120
Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets 118
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 117
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis. 116
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 115
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 114
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 114
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 114
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 110
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 109
Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane 108
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 108
Insights Into the Concept of Rheumatoid Arthritis Flare 105
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 103
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis 100
Established rheumatoid arthritis. The pathogenic aspects. 100
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 99
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 98
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives 98
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases 98
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 98
Meccanismi di danno articolare in corso di artrite reumatoide 97
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 97
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis 97
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 96
Nuovi aspetti patogenetici dell’artrite reumatoide 96
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 95
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment 95
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials 94
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat 93
Synovial tissue heterogeneity and peripheral blood biomarkers 91
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling 89
Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria? 86
Lymphoid tissue reactions in rheumatoid arthritis 86
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs 84
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency 84
La membrana sinoviale 83
Human single-chain variable fragment that specifically targets arthritic cartilage 82
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. 82
Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure 82
Clinical Applications of Synovial Biopsy. 81
Seronegative rheumatoid arthritis: one year in review 2023 79
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease 77
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic 77
The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis 75
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases 75
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis 73
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter-Determining Validation Requirements 73
La linfoneogenesi 72
Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice 71
The Clinical Value of Autoantibodies in Rheumatoid Arthritis. 71
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups. 69
The synovial membrane as a prognostic tool in rheumatoid arthritis 68
Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice 68
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint 64
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: A consensus of the eular synovitis and omeract synovial tissue biopsy groups (Arthritis Research and Therapy (2018) 20 (265) DOI: 10.1186/s13075-018-1762-1) 63
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course 63
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis 62
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors 62
Histopathology of the synovial tissue: Perspectives for biomarker development in chronic inflammatory arthritides. 57
Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective 57
ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis 56
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. 54
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 46
ERRATUM to: Synovial tissue research: a state-of-the-art review (Nature Reviews Rheumatology 13, 463–475 (2017)) 39
Totale 7.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022260 0 0 0 12 3 19 4 28 10 9 38 137
2022/20231.018 107 75 6 72 94 93 2 57 402 10 34 66
2023/2024478 39 110 17 33 39 140 13 28 4 8 28 19
2024/20251.133 20 86 16 15 10 54 77 61 289 57 155 293
2025/20262.704 218 217 333 272 284 106 511 159 200 193 124 87
2026/2027809 37 202 196 374 0 0 0 0 0 0 0 0
Totale 7.975